Federal Regulation

You are here

DOT Rule 49 CFR Part 40 Appendix C

Appendix C to Part 40-DOT Drug Testing Semi-Annual Laboratory Report to DOT

Mail, fax, or email to:
U.S. Department of Transportation
Office of Drug and Alcohol Policy and Compliance
1200 New Jersey Avenue, S.E. Washington, DC 20590
Fax: (202) 366-3897
Email: ODAPCWebMail@dot.gov
Email links icon
The following items are required on each report:
Reporting Period: (inclusive dates)
Laboratory Identification: (name and address)
1. DOT Specimen Results Reported (total number)
2. Negative Results Reported (total number)
Negative (number)
Negative-Dilute (number)
3. Rejected for Testing Results Reported (total number) By Reason
(a) Fatal flaw (number)
(b) Uncorrected Flaw (number)
4. Positive Results Reported (total number) By Drug
(a) Marijuana Metabolite (number)
(b) Cocaine Metabolite (number)
(c) Opioids (number)
(1) Codeine (number)
(2) Morphine (number)
(3) 6–AM (number)
(4) Hydrocodone (number)
(5) Hydromorphone (number)
(6) Oxycodone (number)
(7) Oxymorphone (number)
(d) Phencyclidine (number)
(e) Amphetamines (number)
(1) Amphetamine (number)
(2) Methamphetamine (number)
(3) MDMA (number)
(4) MDA (number)
5. Adulterated Results Reported (total number) By Reason (number)
6. Substituted Results Reported (total number)
7. Invalid Results Reported (total number) By Reason (number)
[73 FR 35975, June 25, 2008, as amended 75 FR 49864, August 16, 2010; 82 FR 52247, November 13, 2017]
Updated: Friday, July 27, 2018
Submit Feedback >